Idea Men, LLC
Known title: 10% OwnerCIK: 0001822195
Associated companies
Transaction History
| GDRX | ▼ Sell | Other | 7,000,000 | $29.4M | 3/21/2025 | View on chart |
| GDRX | ▼ Sell | Other | 7,000,000 | — | 3/21/2025 | View on chart |
| GDRX | ▼ Sell | Open Market | 2,600 | $86K | 1/3/2022 | View on chart |
| GDRX | ▼ Sell | Other | 2,600 | $0 | 1/3/2022 | View on chart |
| GDRX | ▼ Sell | Open Market | 50,855 | $1.9M | 12/3/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 89,231 | $3.3M | 12/3/2021 | View on chart |
| GDRX | ▼ Sell | Other | 166,208 | $0 | 12/3/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 26,122 | $1.0M | 12/3/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 61,722 | $2.3M | 12/2/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 45,529 | $1.8M | 12/2/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 9,422 | $374K | 12/2/2021 | View on chart |
| GDRX | ▼ Sell | Other | 116,673 | $0 | 12/2/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 98,072 | $3.8M | 12/1/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 49,983 | $2.0M | 12/1/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 78,844 | $3.2M | 12/1/2021 | View on chart |
| GDRX | ▼ Sell | Other | 226,899 | $0 | 12/1/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 12,911 | $559K | 11/3/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 98,592 | $4.5M | 11/3/2021 | View on chart |
| GDRX | ▼ Sell | Other | 156,132 | $0 | 11/3/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 44,629 | $2.0M | 11/3/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 75 | $3K | 11/2/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 67,377 | $2.9M | 11/2/2021 | View on chart |
| GDRX | ▼ Sell | Other | 84,025 | $0 | 11/2/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 16,573 | $711K | 11/2/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 68,141 | $3.0M | 11/1/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 1,900 | $85K | 11/1/2021 | View on chart |
| GDRX | ▼ Sell | Other | 70,041 | $0 | 11/1/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 157,254 | $6.5M | 9/30/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 10,303 | $428K | 9/30/2021 | View on chart |
| GDRX | ▼ Sell | Other | 167,557 | $0 | 9/30/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 121,197 | $4.8M | 9/29/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 145,529 | $5.9M | 9/29/2021 | View on chart |
| GDRX | ▼ Sell | Other | 266,726 | $0 | 9/29/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 284,254 | $11.4M | 9/28/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 28,787 | $1.2M | 9/28/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 9,900 | $415K | 9/28/2021 | View on chart |
| GDRX | ▼ Sell | Other | 322,941 | $0 | 9/28/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 215,756 | $9.2M | 9/27/2021 | View on chart |
| GDRX | ▼ Sell | Open Market | 75,488 | $3.3M | 9/27/2021 | View on chart |
| GDRX | ▼ Sell | Other | 291,244 | $0 | 9/27/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
GoodRx Expands Savings Offering With Companion Family Plan for Pets and People
GoodRx has launched a Companion Family Plan that extends its healthcare savings to pets as well as household members. The company is positioning the new offering as a way to bring prescription and care discounts to the entire family, including animals, broadening the appeal of its platform. Separately, a recent market analysis listed GoodRx among stocks viewed as having mixed momentum. The company is already trading near a well-tested support level, providing some technical context around the announcement.
GoodRx Expands Savings Offering With Companion Family Plan for Pets and People. GoodRx has launched a Companion Family Plan that extends its healthcare savings to pets as well as household members. The company is positioning the new offering as a way to bring prescription and care discounts to the entire family, including animals, broadening the appeal of its platform. Separately, a recent market analysis listed GoodRx among stocks viewed as having mixed momentum. The company is already trading near a well-tested support level, providing some technical context around the announcement.